Stephen Rice, MD
Vascular & Interventional Radiology · Alexandria, LANPI 1144228495
Payments from drug & device makers
What this record shows
8 manufacturers reported payments, led by Terumo Medical Corporation at 46.7% of the total. 2025 is the largest year on record at $1,211, more than ten times the $71 reported in 2020. That places this record below the midpoint for vascular & interventional radiology clinicians in LA, where the typical reported total is $3,137.
Across 37 payments — averaging $76.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Terumo Medical Corporation$1K
- Medtronic$1K
- GE HealthCare$117
- Philips North America LLC$96
- Penumbra, Inc.$91
- Abbott$56
- plus $48 from 2 others
What the payments were for
- Travel & lodging$1,62757%
- Food & beverage$1,22043%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Terumo Medical Corporation | 17 | $1,330 |
| Medtronic(2 entities) | 13 | $1,107 |
| GE HealthCare | 1 | $117 |
| Philips North America LLC | 1 | $96 |
| Penumbra, Inc. | 1 | $91 |
| Abbott | 2 | $56 |
| Geron Corporation | 1 | $28 |
| Cardiovascular Systems Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,846 in reported general payments places this provider in the 45th percentile of 42 vascular & interventional radiology providers in Louisiana.
See all vascular & interventional radiology providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 71 | $46,747 |
| ClopidogrelClopidogrel Bisulfate | 124 | $1,497 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Alexandria
- William LongAlexandria$92K
- Daniel HarperAlexandria$9K
- Stuart HeadAlexandria$446
- Juan GimenezNew Orleans$564K
- Tyler SandowNew Orleans$485K
- James MilburnCovington$260K
- Richard Marshall JrNew Orleans$216K
- Hugo Cuellar SaenzShreveport$160K
- David KirschNew Orleans$42K
- Kyle DegeyterLafayette$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.